New federal data from Colorado shows that marijuana use among teens in the state has declined in the years since adult-use legalization.
Researchers at John Hopkins Medicine have uncovered a possible explanation for how marijuana may damage the teenage brain using experiments involving adolescent mice.
A survey conducted by The Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney found that 61.5 percent of General Practitioners reported one or more patients had asked about medical cannabis in the past three months.
An eight year old suffering from epilepsy in Ireland is now completely off all of her prescription medication and solely being treated with cannabis oil.
It is a well documented fact that cannabis use often triggers an appetite for those consuming it. However, until a new study out of Washington State University, very little was known about how or why it does.
B.C. Cancer will lead a first-ever national clinical trial to determine whether cannabis plant extracts truly help with symptom relief. The trial will examine how cannabis properties affect and possibly reduce cancer-related symptoms including pain, sleep disturbance, anxiety and nausea.
Depression is something that many people deal with and struggle to treat. But as mental health awareness becomes more and more prominent, people have begun to test and share different ways to cope with the illness that can be crippling at times.
The Canadian arthritis society has dedicated a page on its website to those considering medical cannabis as a means to treat their pain and inflammation.
Following the legalization of cannabis in Canada, dental hygienists are warning patients that increased smoking can be harmful to their oral health.
Speaking at Digestive Disease Week in Washington, two doctors, one from Toronto’s Mount Sinai hospital, and the other from Meir General hospital in Israel, gave separate presentations on cannabis treatments for inflammatory bowel disease (IBD) and ulcerative colitis (UC).
A new study presented this week found that cannabis may be an effective treatment for headache management.
Newstrike Cannabis and its subsidiary Up Cannabis have ordered a recall of a cannabis product sold in Alberta due to concerns about exceeding mould and microbial contamination levels.
Emerald Health Services majority owned subsidiary Nemus Biosciences (NMUS) has developed its lead product to treat glaucoma using cannabinoids.
A write up in medical news today summed up how and why patients are using CBD to help treat their arthritis.
Anxiety is an issue that many North American adults experience and can have crippling consequences in extreme cases. There are many pharmaceutically prescribed drugs out there that aim to address the issue such as Xanax and valium, but most, if not all, can come with brutal side effects.
In a new profile released by the Globe and Mail, retired NHL enforcer Riley Cote sets to explain how and why he became one of the biggest advocates for medical marijuana in the NHL’s ear.
C.J. Harris, a Highschool football player who was recruited to Auburn University has lost his spot on the roster because his use of medically prescribed cannabis oil violated NCAA rules.
A new study from Statistics Canada analyzing wastewater to track cannabis usage suggests Halifax is consuming more marijuana than any other other major Canadian city.
A new observational study that will have women use a cannabis-based suppository pill aims to determine the effects cannabis can have on menstrual symptoms for women.
Health Canada has approved Tetra Bio-Pharma Inc’s protocol for a clinical trial investigating its PPP001 drug as an alternative to fentanyl in the management of breakthrough cancer pain.
Canopy Growth Corporation announced on Wednesday that it has received approval from Health Canada for clinical trials into the effectiveness of cannabidiol (CBD) in treating animals with anxiety.
Jamaica’s Science and Technology Minister Dr Andrew Wheatley is pushing for his country to “stake its claim” on the island’s unique marijuana strains for research and development.
There has been many back and forth in the scientific community on if medical marijuana can help patients suffering with depression, or if it can actually make it worse or even cause it.
A study published in the Drug and Alcohol Dependence Journal thursday found that the amount of baby boomers using marijuana has doubled since 2006.
Medical cannabis has be cited as a treatment for many different issues, however due to the lack of proper and complete studies, conclusive evidence is almost impossible to find.
Massachusetts-based wellness center Lyme Awareness has added medical cannabis to its list of treatments to help patients with Lyme disease. Although it will not cure the disease, cannabis can be used to aid in symptom management mainly because of its anti-inflammatory properties.
A study out of Montreal that is trying to determine if cannabis can be used as a safer alternative for opiate-based painkillers is having great results thus far.
Attention-deficit/hyperactivity disorder and its association with cannabis is something that has been debated among various parties anecdotally for decades.
Interim director of the MSU Center for Research on Ingredient Safety Norbert Kaminski, has begun a yearlong preclinical study exploring cannabis compounds and their ability to slow the progress of Parkinson’s, Alzheimer’s and other brain diseases.
A mother that has seen her child on a laundry list of pharmaceutical drugs says that medical marijuana has been a miracle for her boys illnesses.
A new partnership between Auckland University of Technology (AUT) and PharmaCann New Zealand Ltd. aims to increase scientific understanding of the ways in which cannabis and cannabis derivatives can benefit health.
At an hour-long special presentation, New Jersey State Health Commissioner Shereef Elnahal stated it was his goal to “demystify” medical marijuana because of the work it is doing for thousands of patients.
A new study published in the Journal of Sexual Medicine (JSM) reveals what most cannabis users have been claiming for years: that cannabis can enhance the sexual experience.
A new study that has been published in the Medicines journal titled “Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia Under Naturalistic Conditions,” found that medical cannabis flower can significantly improve perceived insomnia.
A new study is showcasing that ingesting marijuana even after giving birth can affect a babies development if its mother is breastfeeding.
A new study from a team at the University of New Mexico went through 13,638 user rated cannabis sessions and their effects from 2,830 patients. The results, published in the journal Frontiers in Pharmacology found that patients find relief from a massive amount of symptoms when using medical marijuana.
27 year old free agent Mike James has filed a therapeutic use exemption (TUE) for medical marijuana to the National Football League.
Ontario-based Tetra Bio-Pharma Inc., a Canadian licensed producer, and Panag Pharma Inc. have announced they are coming together to develop a drug to treat animals. The two companies recently announced they have submitted an application to the Veterinary Drugs Directorate at Health Canada for a study to examine the use of a cannabis-based drug to treat ocular pain and inflammation in canines.
Researchers out of Boston found that abstaining from cannabis use for a month can boost the memory function of young people, but has no effect on attention skills.
Researchers at Washington State University have observed the effects of cannabis on the offspring of rats who were given marijuana while pregnant. The study is among one of the few that is looking at the issue of cannabis use while pregnant, despite it being the most commonly used illicit substance among pregnant women.
Scythian Biosciences Corp. and its partners at the University of Miami Miller School of Medicine announced the results of a pre-clinical study evaluating the safety and efficacy of a cannabis derived combination therapy in treating mild to moderate traumatic brain injury (TBI) in rodents.
The world famous Toronto-based children's hospital Sick Kids has completed its study on cannabis oil and its use as a treatment for epilepsy in children.
New research out of the UK suggests a single dose of CBD can help reduce psychotic symptoms. According to the research, when suspected psychosis patients are given a single 600 mg oral dose of the compound cannabidiol (CBD), their symptoms become less severe.
A groundbreaking study by a team at Harvard University has found that an active ingredient in cannabis, tetrahydrocannabinol (THC), was able to cut tumor growth in common lung cancer in half and significantly reduce the ability of the cancer to spread.
A new study has found that cannabis oil “significantly” improves Crohn’s disease symptoms.
A study reported at the 3rd Congress of the European Academy of Neurology released its results that the active compounds in cannabis were better at stifling migraine pain than prescription pharmaceuticals.
Researchers at the British Columbia Centre for Substances Use found that those with PTSD who were using medical marijuana were 60-65 percent less likely to have major depressive episode or thoughts of suicide compared with those not using medical marijuana.
A team of researchers at McGill University have found the proper dosage of CBD to alleviate anxiety and pain issues without having to deal with the high that THC brings on.
A study produced by Whistler Therapeutics was able to identify a correlation between the type of cannabis strain a patient used and its positive or negative effects on their condition.
A study out of McMaster University that performed a systematic review of 17 randomized clinical trials involving 3,161 patients found that though medical cannabis is safe to use, its role in the treatment of multiple sclerosis (MS) symptoms is not well-defined.
A study out of Augusta University in Georgia has found there is a potential benefit to using cannabinoids for treating melanoma in a murine model.
A recent study published in the journal Frontiers last month shed some light on how cannabidiol (CBD) oil can help dogs suffering from osteoarthritis.
A new report out of the University of Bonn in Germany revealed that marijuana boosted the brain power of older mice.
A study out of Johns Hopkins Medicine has shown that, compared to smoking, vaping cannabis increases the effects of marijuana on new or infrequent users, highlighting the importance of proper dosing for medical patients.
A research initiative between Sundial Growers and the University of Saskatchewan will aim to determine whether cannabis could help improve quality of life for people with dementia.
A teenager who missed eight years of school due to chronic fatigue has made a recovery after taking cannabis oil, according to his mother.
With the rapid growth of medical cannabis sweeping across the world, patients are getting more power in how they choose to be treated. Industry leaders, seeing the need for alternatives to the age-old ways of ingestion (smoking, edibles, etc.), have innovated to provide better patient experiences. Among these innovations comes the vaporizer, which every medical cannabis patient should consider as one of their first options.
A third identified receptor in the human endocannabinoid system was studied last year to focus on the potential of the “GPR55 Receptor” and its connection with medical cannabis.
The recently developed Cannabis Research Initiative at the University of California, Los Angeles (UCLA) is determined to test marijuana’s effectiveness to treating pain. Led by Dr. Jeffrey Chen, they intend to gather in-depth research on cannabis, its effects on pain, and its potential as an alternative to opioids.
The University of British Columbia is moving forward on its goal of filling the cannabis research gap, and has created a new professorship to study the possibility of using medical marijuana in treating opioid addictions.
The University of British Columbia is setting up Canada’s first professorship to research how cannabis can play a role in the opioid crisis that has gripped the country.
Pre-clinical research from the University of Guelph found that a cannabis compound that does not have the “high” effect can help to alleviate nausea in chemotherapy patients.
The United States Federal Government is seeking out researchers to investigate how marijuana’s cannabinoids and terpenes work and whether they can treat pain.
An article in the BBC Three this week has detailed the rising popularity of using cannabis to enhance the sexual experience for many couples.
Glaucoma is a serious issue for patients around the world that is the leading cause of irreversible blindness. Most often caused by elevated intraocular pressure, it damages the optic nerve and stops the brain and the eye from communicating the information vital to sight.
The Vancouver School Board is taking an active approach to ensuring its students are educated about the marijuana ahead of legalization.
As medical marijuana continues to attract daily headlines, a certain by product of the plant is beginning to get its well-deserved attention. Cannabidiol (pronounced canna-bid-eye-ol) better known as “CBD” is the compound found in the cannabis plant that is showing the most signs for medical treatment. A cousin of the compound Tetrahydrocannabinol (or THC), the compound found in marijuana that gives users the “high” feeling, CBD provides the benefits to patients without the buzz.
In an Op-Ed for the Orange County Register, Whoopi Goldberg gave a testimony speaking of the benefits of medical cannabis for women.
A joint venture between 20 researchers across 13 institutions in the United States, Australia, and the United Kingdom has found that marijuana use did not affect the volumes of gray matter in the participants brains.